FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development SummaryThe FDA has released new draft guidance providing a standardized “roadmap” for using next-generation sequencing to evaluate off-target risks, aiming to safely accelerate the development of transformative gene therapies for rare and incurable diseases. Click to see the full article 5 […]